MYO Myomo Inc

Price (delayed)

$5.55

Market cap

$159.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.27

Enterprise value

$154.97M

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the ...

Highlights
The EPS has soared by 78% YoY and by 3.6% QoQ
The company's gross profit rose by 32% YoY
The company's debt fell by 19% QoQ but it rose by 9% YoY
The quick ratio has contracted by 17% YoY but it has grown by 11% from the previous quarter

Key stats

What are the main financial stats of MYO
Market
Shares outstanding
28.81M
Market cap
$159.92M
Enterprise value
$154.97M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
14.51
Price to sales (P/S)
10.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.93
Earnings
Revenue
$19.55M
EBIT
-$9.14M
EBITDA
-$8.69M
Free cash flow
-$7.76M
Per share
EPS
-$0.27
Free cash flow per share
-$0.21
Book value per share
$0.38
Revenue per share
$0.53
TBVPS
$0.45
Balance sheet
Total assets
$16.52M
Total liabilities
$5.62M
Debt
$486,113
Equity
$10.9M
Working capital
$10.15M
Liquidity
Debt to equity
0.04
Current ratio
2.83
Quick ratio
2.28
Net debt/EBITDA
0.57
Margins
EBITDA margin
-44.4%
Gross margin
67.4%
Net margin
-47.8%
Operating margin
-48.3%
Efficiency
Return on assets
-60.8%
Return on equity
-94%
Return on invested capital
-212.6%
Return on capital employed
-83.4%
Return on sales
-46.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MYO stock price

How has the Myomo stock price performed over time
Intraday
-1.42%
1 week
11.9%
1 month
71.3%
1 year
599.87%
YTD
10.78%
QTD
72.9%

Financial performance

How have Myomo's revenue and profit performed over time
Revenue
$19.55M
Gross profit
$13.17M
Operating income
-$9.45M
Net income
-$9.34M
Gross margin
67.4%
Net margin
-47.8%
The company's gross profit rose by 32% YoY
The operating margin has grown by 31% YoY but it has contracted by 13% from the previous quarter
The company's net margin rose by 31% YoY but it fell by 13% QoQ
The revenue has increased by 29% year-on-year

Growth

What is Myomo's growth rate over time

Valuation

What is Myomo stock price valuation
P/E
N/A
P/B
14.51
P/S
10.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.93
The EPS has soared by 78% YoY and by 3.6% QoQ
The price to book (P/B) is 120% more than the last 4 quarters average of 6.7
MYO's equity is up by 21% since the previous quarter and by 13% year-on-year
The stock's P/S is 152% above its last 4 quarters average of 4.2
The revenue has increased by 29% year-on-year

Efficiency

How efficient is Myomo business performance
Myomo's return on invested capital has surged by 73% YoY and by 19% QoQ
The ROS rose by 33% YoY but it fell by 13% QoQ
The return on assets has grown by 27% year-on-year but it has declined by 10% since the previous quarter
MYO's ROE is up by 24% year-on-year but it is down by 11% since the previous quarter

Dividends

What is MYO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MYO.

Financial health

How did Myomo financials performed over time
Myomo's total assets is 194% higher than its total liabilities
The total liabilities has grown by 37% YoY
Myomo's total assets has increased by 20% YoY and by 13% QoQ
The company's debt is 96% lower than its equity
The debt to equity has decreased by 43% QoQ and by 20% YoY
MYO's equity is up by 21% since the previous quarter and by 13% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.